Weber JA, Baxter DH, Zhang S, Huang DY, Huang KH, Lee MJ, Galas DJ, Wang K. The microRNA spectrum in 12 body fluids. Clin Chem. 2010 Nov;56(11):1733-41. Epub 2010 Sep 16. PMID: 20847327; PMCID: PMC4846276. https://doi.org/10.1373/clinchem.2010.147405.
DOI: 10.1373/clinchem.2010.147405

Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X, Li Q, Li X, Wang W, Zhang Y, Wang J, Jiang X, Xiang Y, Xu C, Zheng P, Zhang J, Li R, Zhang H, Shang X, Gong T, Ning G, Wang J, Zen K, Zhang J, Zhang CY. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008 Oct;18(10):997-1006. PMID: 18766170. https://doi.org/10.1038/cr.2008.282.
DOI: 10.1038/cr.2008.282

Garzon R, Croce CM. MicroRNAs in normal and malignant hematopoiesis. Curr Opin Hematol. 2008 Jul;15(4):352-8. PMID: 18536574. https://doi.org/10.1097/MOH.0b013e328303e15d.
DOI: 10.1097/MOH.0b013e328303e15d

Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y, Mitsudomi T, Takahashi T. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 2004 Jun 1;64(11):3753-6. PMID: 15172979. https://doi.org/10.1158/0008-5472.CAN-04-0637.
DOI: 10.1158/0008-5472.CAN-04-0637

Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE, Iorio MV, Visone R, Sever NI, Fabbri M, Iuliano R, Palumbo T, Pichiorri F, Roldo C, Garzon R, Sevignani C, Rassenti L, Alder H, Volinia S, Liu CG, Kipps TJ, Negrini M, Croce CM. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med. 2005 Oct 27;353(17):1793-801. Erratum in: N Engl J Med. 2006 Aug 3;355(5):533. PMID: 16251535. https://doi.org/10.1056/NEJMoa050995.
DOI: 10.1056/NEJMoa050995

Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR. MicroRNA expression profiles classify human cancers. Nature. 2005 Jun 9;435(7043):834-8. PMID: 15944708. https://doi.org/10.1038/nature03702.
DOI: 10.1038/nature03702

Nana-Sinkam SP, Croce CM. MicroRNAs as therapeutic targets in cancer. Transl Res. 2011 Apr;157(4):216-25. Epub 2011 Feb 4. PMID: 21420032. https://doi.org/10.1016/j.trsl.2011.01.013.
DOI: 10.1016/j.trsl.2011.01.013

Nagalingam RS, Safi HA, Czubryt MP. Gaining myocytes or losing fibroblasts: Challenges in cardiac fibroblast reprogramming for infarct repair. J Mol Cell Cardiol. 2016 Apr;93:108-14. Epub 2015 Nov 27. PMID: 26640115. https://doi.org/10.1016/j.yjmcc.2015.11.029.
DOI: 10.1016/j.yjmcc.2015.11.029

Richard Y. Cao, Qing Li, Yi Miao, Ying Zhang, Wenchao Yuan, Li Fan, Gongliang Liu, Qiongyao Mi, Jian Yang. The Emerging Role of MicroRNA-155 in Cardiovascular Diseases. BioMed Research International. 2016;2016:9869208. PMID: 28018919. PMCID: PMC5149600. https://doi.org/10.1155/2016/9869208.
DOI: 10.1155/2016/9869208

Wang J, Xu L, Tian L, Sun Q. Circulating microRNA-208 family as early diagnostic biomarkers for acute myocardial infarction: A meta-analysis. Medicine (Baltimore). 2021 Dec 23;100(51):e27779. PMID: 34941030; PMCID: PMC8702233. https://doi.org/10.1097/MD.0000000000027779.
DOI: 10.1097/MD.0000000000027779

Zhao Y, Samal E, Srivastava D. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature. 2005 Jul 14;436(7048):214-20. PMID: 15951802. https://doi.org/10.1038/nature03817.
DOI: 10.1038/nature03817

Nagalla S, Shaw C, Kong X, Kondkar AA, Edelstein LC, Ma L, Chen J, McKnight GS, Lopez JA, Yang L, Jin Y, Bray MS, Leal SM, Dong JF, Bray PF. Platelet microRNA-mRNA coexpression profiles correlate with platelet reactivity. Blood. 2011 May 12;117(19):5189-97. Epub 2011 Mar 17. PMID: 21415270; PMCID: PMC3109541. https://doi.org/10.1182/blood-2010-09-299719.
DOI: 10.1182/blood-2010-09-299719

Procyk G, Klimczak-Tomaniak D, Sygitowicz G, Tomaniak M. Circulating and Platelet MicroRNAs in Cardiovascular Risk Assessment and Antiplatelet Therapy Monitoring. J Clin Med. 2022 Mar 22;11(7):1763. PMID: 35407371; PMCID: PMC8999342. https://doi.org/10.3390/jcm11071763.
DOI: 10.3390/jcm11071763

Siasos G, Bletsa E, Stampouloglou PK, Oikonomou E, Tsigkou V, Paschou SA, Vlasis K, Marinos G, Vavuranakis M, Stefanadis C, Tousoulis D. MicroRNAs in cardiovascular disease. Hellenic J Cardiol. 2020 May-Jun;61(3):165-173. Epub 2020 Apr 17. PMID: 32305497. https://doi.org/10.1016/j.hjc.2020.03.003.
DOI: 10.1016/j.hjc.2020.03.003

Zampetaki A, Willeit P, Drozdov I, Kiechl S, Mayr M. Profiling of circulating microRNAs: from single biomarkers to re-wired networks. Cardiovasc Res. 2012 Mar 15;93(4):555-62. Epub 2011 Oct 25. PMID: 22028337; PMCID: PMC3291086. https://doi.org/10.1093/cvr/cvr266.
DOI: 10.1093/cvr/cvr266

Peters LJF, Biessen EAL, Hohl M, Weber C, van der Vorst EPC, Santovito D. Small Things Matter: Relevance of MicroRNAs in Cardiovascular Disease. Front Physiol. 2020 Jul 7;11:793. PMID: 32733281; PMCID: PMC7358539. https://doi.org/10.3389/fphys.2020.00793.
DOI: 10.3389/fphys.2020.00793

D'Alessandra Y, Devanna P, Limana F, Straino S, Di Carlo A, Brambilla PG, Rubino M, Carena MC, Spazzafumo L, De Simone M, Micheli B, Biglioli P, Achilli F, Martelli F, Maggiolini S, Marenzi G, Pompilio G, Capogrossi MC. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J. 2010 Nov;31(22):2765-73. Epub 2010 Jun 9. PMID: 20534597; PMCID: PMC2980809. https://doi.org/10.1093/eurheartj/ehq167.
DOI: 10.1093/eurheartj/ehq167

Cheng Y, Tan N, Yang J, Liu X, Cao X, He P, Dong X, Qin S, Zhang C. A translational study of circulating cell-free microRNA-1 in acute myocardial infarction. Clin Sci (Lond). 2010 Apr 20;119(2):87-95. PMID: 20218970; PMCID: PMC3593815. https://doi.org/10.1042/CS20090645.
DOI: 10.1042/CS20090645

Su T, Shao X, Zhang X, Yang C, Shao X. Value of circulating miRNA-1 detected within 3 h after the onset of acute chest pain in the diagnosis and prognosis of acute myocardial infarction. Int J Cardiol. 2020 May 15;307:146-151. Epub 2019 Oct 8. PMID: 31611081. https://doi.org/10.1016/j.ijcard.2019.09.050.
DOI: 10.1016/j.ijcard.2019.09.050

Ji X, Takahashi R, Hiura Y, Hirokawa G, Fukushima Y, Iwai N. Plasma miR-208 as a biomarker of myocardial injury. Clin Chem. 2009 Nov;55(11):1944-9. Epub 2009 Aug 20. PMID: 19696117. https://doi.org/10.1373/clinchem.2009.125310.
DOI: 10.1373/clinchem.2009.125310

Wang GK, Zhu JQ, Zhang JT, Li Q, Li Y, He J, Qin YW, Jing Q. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J. 2010 Mar;31(6):659-66. Epub 2010 Feb 16. PMID: 20159880. https://doi.org/10.1093/eurheartj/ehq013.
DOI: 10.1093/eurheartj/ehq013

Corsten MF, Dennert R, Jochems S, Kuznetsova T, Devaux Y, Hofstra L, Wagner DR, Staessen JA, Heymans S, Schroen B. Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease. Circ Cardiovasc Genet. 2010 Dec;3(6):499-506. Epub 2010 Oct 4. PMID: 20921333. https://doi.org/10.1161/CIRCGENETICS.110.957415.
DOI: 10.1161/CIRCGENETICS.110.957415

Xin Y, Yang C, Han Z. Circulating miR-499 as a potential biomarker for acute myocardial infarction. Ann Transl Med. 2016 Apr;4(7):135. PMID: 27162785; PMCID: PMC4842393. https://doi.org/10.21037/atm.2016.03.40.
DOI: 10.21037/atm.2016.03.40

Shalaby SM, El-Shal AS, Shoukry A, Khedr MH, Abdelraheim N. Serum miRNA-499 and miRNA-210: A potential role in early diagnosis of acute coronary syndrome. IUBMB Life. 2016 Aug;68(8):673-82. Epub 2016 Jun 27. PMID: 27346801. https://doi.org/10.1002/iub.1529.
DOI: 10.1002/iub.1529

Wang X, Tian L, Sun Q. Diagnostic and prognostic value of circulating miRNA-499 and miRNA-22 in acute myocardial infarction. J Clin Lab Anal. 2020 Aug;34(8):2410-2417. Epub 2020 Jun 11. PMID: 32529742; PMCID: PMC7439427. https://doi.org/10.1002/jcla.23332.
DOI: 10.1002/jcla.23332

Widera C, Gupta SK, Lorenzen JM, Bang C, Bauersachs J, Bethmann K, Kempf T, Wollert KC, Thum T. Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome. J Mol Cell Cardiol. 2011 Nov;51(5):872-5. Epub 2011 Jul 23. PMID: 21806992. https://doi.org/10.1016/j.yjmcc.2011.07.011.
DOI: 10.1016/j.yjmcc.2011.07.011

Zhang L, Ding H, Zhang Y, Wang Y, Zhu W, Li P. Circulating MicroRNAs: Biogenesis and Clinical Significance in Acute Myocardial Infarction. Front Physiol. 2020 Sep 3;11:1088. PMID: 33013463; PMCID: PMC7494963. https://doi.org/10.3389/fphys.2020.01088.
DOI: 10.3389/fphys.2020.01088

Chistiakov DA, Orekhov AN, Bobryshev YV. Cardiac-specific miRNA in cardiogenesis, heart function, and cardiac pathology (with focus on myocardial infarction). J Mol Cell Cardiol. 2016 May;94:107-121. Epub 2016 Apr 4. PMID: 27056419. https://doi.org/10.1016/j.yjmcc.2016.03.015.
DOI: 10.1016/j.yjmcc.2016.03.015

Abdallah HY, Hassan R, Fareed A, Abdelgawad M, Mostafa SA, Mohammed EA. Identification of a circulating microRNAs biomarker panel for non-invasive diagnosis of coronary artery disease: casecontrol study. BMC Cardiovasc Disord. 2022 Jun 24;22(1):286. PMID: 35751015; PMCID: PMC9233383. https://doi.org/10.1186/s12872-022-02711-9.
DOI: 10.1186/s12872-022-02711-9

Wang D, Yan C. MicroRNA-208a-3p participates in coronary heart disease by regulating the growth of hVSMCs by targeting BTG1. Exp Ther Med. 2022 Jan;23(1):71. Epub 2021 Nov 23. PMID: 34934442; PMCID: PMC8649848. https://doi.org/10.3892/etm.2021.10994.
DOI: 10.3892/etm.2021.10994

Fichtlscherer S, De Rosa S, Fox H, Schwietz T, Fischer A, Liebetrau C, Weber M, Hamm CW, Roxe T, Muller-Ardogan M, Bonauer A, Zeiher AM, Dimmeler S. Circulating microRNAs in patients with coronary artery disease. Circ Res. 2010 Sep 3;107(5):677-84. Epub 2010 Jul 1. PMID: 20595655. https://doi.org/10.1161/CIRCRESAHA.109.215566.
DOI: 10.1161/CIRCRESAHA.109.215566

Yang S, Ye ZM, Chen S, Luo XY, Chen SL, Mao L, Li Y, Jin H, Yu C, Xiang FX, Xie MX, Chang J, Xia YP, Hu B. MicroRNA-23a-5p promotes atherosclerotic plaque progression and vulnerability by repressing ATP-binding cassette transporter A1/G1 in macrophages. J Mol Cell Cardiol. 2018 Oct;123:139-149. Epub 2018 Sep 15. PMID: 30227118. https://doi.org/10.1016/j.yjmcc.2018.09.004.
DOI: 10.1016/j.yjmcc.2018.09.004

Kumarswamy R, Anker SD, Thum T. MicroRNAs as circulating biomarkers for heart failure: questions about MiR-423-5p. Circ Res. 2010 May 14;106(9):e8; author reply e9. Erratum in: Circ Res. 2010 Jul 9;107(1):e4. PMID: 20466983. https://doi.org/10.1161/CIRCRESAHA.110.220616.
DOI: 10.1161/CIRCRESAHA.110.220616

Magnussen C, Blankenberg S. Biomarkers for heart failure: small molecules with high clinical relevance. J Intern Med. 2018 Jun;283(6):530-543. Epub 2018 Apr 22. PMID: 29682806. https://doi.org/10.1111/joim.12756.
DOI: 10.1111/joim.12756

Masson S, Batkai S, Beermann J, Bar C, Pfanne A, Thum S, Magnoli M, Balconi G, Nicolosi GL, Tavazzi L, Latini R, Thum T. Circulating microRNA-132 levels improve risk prediction for heart failure hospitalization in patients with chronic heart failure. Eur J Heart Fail. 2018 Jan;20(1):78-85. Epub 2017 Oct 12. PMID: 2902732. https://doi.org/10.1002/ejhf.961.
DOI: 10.1002/ejhf.961

Ntelios D, Efthimiadis G, Zegkos T, Didagelos M, Katopodi T, Meditskou S, Parcharidou D, Karvounis H, Tzimagiorgis G. Correlation of miR-146a-5p plasma levels and rs2910164 polymorphism with left ventricle outflow tract obstruction in hypertrophic cardiomyopathy. Hellenic J Cardiol. 2021 Sep-Oct;62(5):349-354. Epub 2020 May 7. PMID: 32389629. https://doi.org/10.1016/j.hjc.2020.04.015.
DOI: 10.1016/j.hjc.2020.04.015

Improta-Caria AC, Aras MG, Nascimento L, De Sousa RAL, Aras-Junior R, Souza BSF. MicroRNAs Regulating Renin-Angiotensin-Aldosterone System, Sympathetic Nervous System and Left Ventricular Hypertrophy in Systemic Arterial Hypertension. Biomolecules. 2021 Nov 26;11(12):1771. PMID: 34944415; PMCID: PMC8698399. https://doi.org/10.3390/biom11121771.
DOI: 10.3390/biom11121771

Li S, Zhu J, Zhang W, Chen Y, Zhang K, Popescu LM, Ma X, Lau WB, Rong R, Yu X, Wang B, Li Y, Xiao C, Zhang M, Wang S, Yu L, Chen AF, Yang X, Cai J. Signature microRNA expression profile of essential hypertension and its novel link to human cytomegalovirus infection. Circulation. 2011 Jul 12;124(2):175-84. Epub 2011 Jun 20. PMID: 21690488. https://doi.org/10.1161/CIRCULATIONAHA.110.012237.
DOI: 10.1161/CIRCULATIONAHA.110.012237

Zampetaki A, Kiechl S, Drozdov I, Willeit P, Mayr U, Prokopi M, Mayr A, Weger S, Oberhollenzer F, Bonora E, Shah A, Willeit J, Mayr M. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res. 2010 Sep 17;107(6):810-7. Epub 2010 Jul 22. PMID: 20651284. https://doi.org/10.1161/CIRCRESAHA.110.226357.
DOI: 10.1161/CIRCRESAHA.110.226357

Парфенова Е.В., Ткачук В.А. Влияние гипергликемии на ангиоген-ные свойства эндотелиальных и прогениторных клеток сосудов. Вестник РАМН. 2012;67(1):38-44. [Parfenova E.V., Tkachuk V.A. Hyperglycemia impact on angiogenic properties of endothelial and progenitor vascular cells (in Russ.)]. PMID: 22550709.

Kong L, Zhu J, Han W, Jiang X, Xu M, Zhao Y, Dong Q, Pang Z, Guan Q, Gao L, Zhao J, Zhao L. Significance of serum microRNAs in prediabetes and newly diagnosed type 2 diabetes: a clinical study. Acta Diabetol. 2011 Mar;48(1):61-9. Epub 2010 Sep 21. PMID: 20857148. https://doi.org/10.1007/s00592-010-0226-0.
DOI: 10.1007/s00592-010-0226-0

Jimenez-Lucena R, Camargo A, Alcala-Diaz JF, Romero-Baldonado C, Luque RM, van Ommen B, Delgado-Lista J, Ordovas JM, Perez-Martinez P, Rangel-Zuniga OA, Lopez-MiRanda J. A plasma circulating miRNAs profile predicts type 2 diabetes mellitus and prediabetes: from the CORDIOPREV study. Exp Mol Med. 2018 Dec 26;50(12):1-12. PMID: 30598522; PMCID: PMC6312530. https://doi.org/10.1038/s12276-018-0194-y.
DOI: 10.1038/s12276-018-0194-y

Monjezi, A, Khedri, A, Zakerkish, M. et al. Resistin, TNF-а, and microRNA 124-3p expressions in peripheral blood mononuclear cells are associated with diabetic nephropathy. Int J Diabetes Dev Ctries 42, 62-69 (2022). https://doi.org/10.1007/s13410-021-00966-0.
DOI: 10.1007/s13410-021-00966-0

Heinzer R, Vat S, Marques-Vidal P, Marti-Soler H, Andries D, Tobback N, Mooser V, Preisig M, Malhotra A, Waeber G, Vollenweider P, Tafti M, Haba-Rubio J. Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study. Lancet Respir Med. 2015 Apr;3(4):310-8. Epub 2015 Feb 12. PMID: 25682233; PMCID: PMC4404207. https://doi.org/10.1016/S2213-2600(15)00043-0.
DOI: 10.1016/S2213-2600(15)00043-0

Williams SK, Ravenell J, Jean-Louis G, Zizi F, Underberg JA, McFarlane SI, Ogedegbe G. Resistant hypertension and sleep apnea: pathophysiologic insights and strategic management. Curr Diab Rep. 2011 Feb;11(1):64-9. PMID: 21104207. https://doi.org/10.1007/s11892-010-0161-z.
DOI: 10.1007/s11892-010-0161-z

Barbe F, Duran-Cantolla J, Sanchez-de-la-Torre M, Martinez-Alonso M, Carmona C, Barcelo A, Chiner E, Masa JF, Gonzalez M, Marin JM, Garcia-Rio F, Diaz de Atauri J, Teran J, Mayos M, de la Pena M, Monasterio C, del Campo F, Montserrat JM; Spanish Sleep And Breathing Network. Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: a randomized controlled trial. JAMA. 2012 May 23;307(20):2161-8. PMID: 22618923. https://doi.org/10.1001/jama.2012.4366.
DOI: 10.1001/jama.2012.4366

Martinez-Gartia MA, Capote F, Campos-Rodriguez F, Lloberes P, Dtiz de Atauri MJ, Somoza M, Masa JF, Gonzalez M, Sacristan L, Barbe F, Duran-Cantolla J, Aizpuru F, Manas E, Barreiro B, Mosteiro M, Cebrian JJ, de la Pena M, Gartia-Rto F, Maimo A, Zapater J, Hernandez C, Grau SanMarti N, Montserrat JM; Spanish Sleep Network. Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial. JAMA. 2013 Dec 11;310(22):2407-15. PMID: 24327037. https://doi.org/10.1001/jama.2013.281250.
DOI: 10.1001/jama.2013.281250

Sanchez-de-la-Torre M, Khalyfa A, Sanchez-de-la-Torre A, Martinez-Alonso M, Martinez-Garcia MA, Barcelo A, Lloberes P, Campos-Rodriguez F, Capote F, Diaz-de-Atauri MJ, Somoza M, Gonzalez M, Masa JF, Gozal D, Barbe F; Spanish Sleep Network. Precision Medicine in Patients With Resistant Hypertension and Obstructive Sleep Apnea: Blood Pressure Response to Continuous Positive Airway Pressure Treatment. J Am Coll Cardiol. 2015 Sep 1;66(9):1023-32. PMID: 26314530. https://doi.org/10.1016/j.jacc.2015.06.1315.
DOI: 10.1016/j.jacc.2015.06.1315

Santamaria-Martos F, Benttez I, Ortega F, Zapater A, Giron C, Pinilla L, Pascual L, Cortijo A, Dalmases M, Fernandez-Real JM, Barbe F, Sanchez-de-la-Torre M. Circulating microRNA profile as a potential biomarker for obstructive sleep apnea diagnosis. Sci Rep. 2019 Sep 17;9(1):13456. PMID: 31530881; PMCID: PMC6748919. https://doi.org/10.1038/s41598-019-49940-1.
DOI: 10.1038/s41598-019-49940-1

Campos-Rodriguez F, Martinez-Garcia MA, Martinez M, Duran-Cantolla J, Pena Mde L, Masdeu MJ, Gonzalez M, Campo Fd, Gallego I, Marin JM, Barbe F, Montserrat JM, Farre R; Spanish Sleep Network. Association between obstructive sleep apnea and cancer incidence in a large multicenter Spanish cohort. Am J Respir Crit Care Med. 2013 Jan 1;187(1):99-105. Epub 2012 Nov 15. PMID: 23155146. https://doi.org/10.1164/rccm.201209-1671OC.
DOI: 10.1164/rccm.201209-1671OC